A pilot study titled, "The effect of alpha/theta neurofeedback and alpha-stim treatment of immune function, physical symptoms and subjective stress within a group of HIV+ subjects, a controlled study" is in the process of being completed.

We investigated the effects of neurofeedback training (8-12 Hz, &8 Hz) and Alpha-Stim therapy on 4() subjects with HIV. The goal of the study is to document previously observed clinical changes and to justify the utility of further investigation. Effects were measured over four months by changes in blood panels (T4 helper cells), k physical symptomatology (SCL-90) and subjective measures of stress.

To date, in 10 subjects given neurofeedback therapy only, the group averaged 31% increase in T-4 level. In 10 subjects given neurofeedback and Alpha-Stim, the group averaged 34% increase in T-4 level. All the subjects reported a decrease in physical symptoms and subjective stress within the first month of the study.

The research is currently being completed and will have a control group and Alpha-Stim only group (10 subjects each.) Since the results thus far have been extremely compelling in favor of positive immune modulation with neurofeedback, the authors would like to offer the preliminary data to interested researchers and clinicians so they may replicate the study and/or utilize the protocol in clinical practice. At present, the authors are analyzing the data and will be prepared to discuss both the preliminary results of this research as well as to offer a theoretical model for why the immune system would be amenable to neurofeedback.